Krystal Biotech, Inc. (KRYS)
363.84
+4.48
(+1.25%)
USD |
NASDAQ |
Sep 01, 16:00
363.72
-0.12
(-0.03%)
After-Hours: 20:00
Krystal Biotech Cash and Short Term Investments (Quarterly) : 845.63M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 845.63M |
| March 31, 2026 | 823.40M |
| December 31, 2025 | 827.79M |
| September 30, 2025 | 731.07M |
| June 30, 2025 | 681.99M |
| March 31, 2025 | 616.85M |
| December 31, 2024 | 597.52M |
| September 30, 2024 | 588.32M |
| June 30, 2024 | 559.61M |
| March 31, 2024 | 538.26M |
| December 31, 2023 | 532.18M |
| September 30, 2023 | 562.07M |
| June 30, 2023 | 477.52M |
| March 31, 2023 | 350.39M |
| December 31, 2022 | 379.17M |
| September 30, 2022 | 394.42M |
| June 30, 2022 | 425.56M |
| March 31, 2022 | 434.63M |
| December 31, 2021 | 438.10M |
| September 30, 2021 | 343.09M |
| Date | Value |
|---|---|
| June 30, 2021 | 367.73M |
| March 31, 2021 | 403.42M |
| December 31, 2020 | 271.26M |
| September 30, 2020 | 286.36M |
| June 30, 2020 | 297.17M |
| March 31, 2020 | 186.70M |
| December 31, 2019 | 193.68M |
| September 30, 2019 | 203.21M |
| June 30, 2019 | 195.47M |
| March 31, 2019 | 106.63M |
| December 31, 2018 | 111.76M |
| September 30, 2018 | 52.29M |
| June 30, 2018 | 45.45M |
| March 31, 2018 | 47.23M |
| December 31, 2017 | 49.59M |
| September 30, 2017 | 52.57M |
| June 30, 2017 | 3.518M |
| March 31, 2017 | 1.959M |
| December 31, 2016 | 1.923M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 11.92M |
| TG Therapeutics, Inc. | 552.25M |
| Cytokinetics, Inc. | 1.169B |
| ADMA Biologics, Inc. | 136.02M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |